Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 2/2014

Open Access 01-02-2014 | Original Article

Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients

Authors: Thida Win, Benjamin A. Thomas, Tryphon Lambrou, Brian F. Hutton, Nicholas J. Screaton, Joanna C. Porter, Toby M. Maher, Raymondo Endozo, Robert I. Shortman, Asim Afaq, Pauline Lukey, Peter J. Ell, Ashley M. Groves

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2014

Login to get access

Abstract

Purpose

Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of normal-appearing lung on HRCT in IPF.

Methods

Consecutive IPF patients (22 men, 3 women) were prospectively recruited. The patients underwent 18F-FDG PET/HRCT. The pulmonary imaging findings in the IPF patients were compared to the findings in a control population. Pulmonary uptake of 18F-FDG (mean SUV) was quantified at sites of morphologically normal parenchyma on HRCT. SUVs were also corrected for tissue fraction (TF). The mean SUV in IPF patients was compared with that in 25 controls (patients with lymphoma in remission or suspected paraneoplastic syndrome with normal PET/CT appearances).

Results

The pulmonary SUV (mean ± SD) uncorrected for TF in the controls was 0.48 ± 0.14 and 0.78 ± 0.24 taken from normal lung regions in IPF patients (p < 0.001). The TF-corrected mean SUV in the controls was 2.24 ± 0.29 and 3.24 ± 0.84 in IPF patients (p < 0.001).

Conclusion

IPF patients have increased pulmonary uptake of 18F-FDG on PET in areas of lung with a normal morphological appearance on HRCT. This may have implications for determining disease mechanisms and treatment monitoring.
Literature
1.
go back to reference Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150:967–72.PubMedCrossRef Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150:967–72.PubMedCrossRef
2.
go back to reference Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:810–6.PubMedCrossRef Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:810–6.PubMedCrossRef
4.
5.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.PubMedCrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.PubMedCrossRef
6.
go back to reference Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, et al. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG-PET/CT. J Nucl Med. 2009;50:538–45.PubMedCrossRef Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, et al. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG-PET/CT. J Nucl Med. 2009;50:538–45.PubMedCrossRef
7.
go back to reference Umeda Y, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Saito Y, et al. Dual-time-point (18)F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur J Nucl Med Mol Imaging. 2009;36:1121–30.PubMedCrossRef Umeda Y, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Saito Y, et al. Dual-time-point (18)F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur J Nucl Med Mol Imaging. 2009;36:1121–30.PubMedCrossRef
8.
go back to reference Nusair S, Rubinstein R, Freedman NM, Amir G, Bogot NR, Izhar U, et al. Positron emission tomography in interstitial lung disease. Respirology. 2007;12:843–7.PubMedCrossRef Nusair S, Rubinstein R, Freedman NM, Amir G, Bogot NR, Izhar U, et al. Positron emission tomography in interstitial lung disease. Respirology. 2007;12:843–7.PubMedCrossRef
9.
go back to reference Meissner H, Soo Hoo GW, Khonsary SA, Mandelkern M, Brown CV, Santiago SM. Idiopathic pulmonary fibrosis: evaluation with positron emission tomography. Respiration. 2006;73:197–202.PubMed Meissner H, Soo Hoo GW, Khonsary SA, Mandelkern M, Brown CV, Santiago SM. Idiopathic pulmonary fibrosis: evaluation with positron emission tomography. Respiration. 2006;73:197–202.PubMed
10.
go back to reference Ambrosini V, Zompatori M, De Luca F, Antonia D, Allegri V, Nanni C, et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. J Nucl Med. 2010;51:1950–5.PubMedCrossRef Ambrosini V, Zompatori M, De Luca F, Antonia D, Allegri V, Nanni C, et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. J Nucl Med. 2010;51:1950–5.PubMedCrossRef
11.
go back to reference Win T, Screaton NJ, Porter JC, Endozo R, Kayani I, Dickson J, et al. Novel PET/CT imaging of diffuse parenchymal lung disease combining a labelled somatostatin receptor analogue and 18F-FDG. Mol Imaging. 2012;11:91–8.PubMed Win T, Screaton NJ, Porter JC, Endozo R, Kayani I, Dickson J, et al. Novel PET/CT imaging of diffuse parenchymal lung disease combining a labelled somatostatin receptor analogue and 18F-FDG. Mol Imaging. 2012;11:91–8.PubMed
12.
go back to reference Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, et al. Fast free-form deformation using graphics processing units. Comput Methods Prog Biomed. 2010;98:278–84.CrossRef Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, et al. Fast free-form deformation using graphics processing units. Comput Methods Prog Biomed. 2010;98:278–84.CrossRef
13.
go back to reference Lambrou T, Groves AM, Erlandsson K, Win T, Screaton N, Porter JC, et al. The importance of correction for tissue fraction effects in lung PET; preliminary investigation. Eur J Nucl Med Mol Imaging. 2011;38:2238–46.PubMedCrossRef Lambrou T, Groves AM, Erlandsson K, Win T, Screaton N, Porter JC, et al. The importance of correction for tissue fraction effects in lung PET; preliminary investigation. Eur J Nucl Med Mol Imaging. 2011;38:2238–46.PubMedCrossRef
14.
go back to reference Win T, Lambrou T, Hutton BF, Screaton N, Porter JC, Maher T, et al. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. Eur J Nucl Med Mol Imaging. 2012;39:521–8.PubMedCrossRef Win T, Lambrou T, Hutton BF, Screaton N, Porter JC, Maher T, et al. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials. Eur J Nucl Med Mol Imaging. 2012;39:521–8.PubMedCrossRef
15.
go back to reference Hamid Q, Martin J, Shannon J. Physiological basis of respiratory disease. Hamilton, Ontario: BC Decker; 2005. Hamid Q, Martin J, Shannon J. Physiological basis of respiratory disease. Hamilton, Ontario: BC Decker; 2005.
16.
go back to reference Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J. 2002;19:275–83.PubMedCrossRef Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J. 2002;19:275–83.PubMedCrossRef
17.
go back to reference Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301–15.PubMedCrossRef Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301–15.PubMedCrossRef
18.
go back to reference Goodwin A, Jenkins G. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis. Biochem Soc Trans. 2009;37:849–54.PubMedCrossRef Goodwin A, Jenkins G. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis. Biochem Soc Trans. 2009;37:849–54.PubMedCrossRef
Metadata
Title
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
Authors
Thida Win
Benjamin A. Thomas
Tryphon Lambrou
Brian F. Hutton
Nicholas J. Screaton
Joanna C. Porter
Toby M. Maher
Raymondo Endozo
Robert I. Shortman
Asim Afaq
Pauline Lukey
Peter J. Ell
Ashley M. Groves
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2514-8

Other articles of this Issue 2/2014

European Journal of Nuclear Medicine and Molecular Imaging 2/2014 Go to the issue